Healthpeak Properties (NYSE:DOC) Price Target Raised to $21.00

Healthpeak Properties (NYSE:DOC) had its price target lifted by Royal Bank Of Canada from $20.00 to $21.00 in a research note published on Thursday,Benzinga reports. The firm currently has an outperform rating on the real estate investment trust’s stock.

DOC has been the topic of a number of other reports. Evercore cut Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target on the stock. in a research note on Monday, May 11th. Wall Street Zen upgraded Healthpeak Properties from a “sell” rating to a “hold” rating in a research note on Sunday, May 10th. Citigroup increased their price objective on Healthpeak Properties from $17.50 to $20.00 and gave the company a “neutral” rating in a research note on Tuesday. Morgan Stanley reduced their price objective on Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 28th. Finally, Argus cut Healthpeak Properties from a “buy” rating to a “hold” rating in a research note on Thursday, February 5th. Five equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $18.92.

Healthpeak Properties Trading Down 1.0%

Shares of Healthpeak Properties stock opened at $19.36 on Thursday. The firm has a market capitalization of $13.35 billion, a price-to-earnings ratio of 60.50, a PEG ratio of 2.67 and a beta of 1.00. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $19.91. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The stock has a 50 day moving average of $17.26 and a 200 day moving average of $17.21.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.02. The company had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, research analysts predict that Healthpeak Properties will post 1.75 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The firm also recently declared a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be paid a $0.1017 dividend. The ex-dividend date is Monday, June 15th. This represents a c) dividend on an annualized basis and a yield of 6.3%. Healthpeak Properties’s dividend payout ratio (DPR) is currently 381.25%.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the sale, the insider directly owned 7,636 shares in the company, valued at $148,520.20. This trade represents a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.23% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Healthpeak Properties

Several hedge funds have recently made changes to their positions in DOC. WPG Advisers LLC grew its holdings in shares of Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock worth $26,000 after purchasing an additional 1,197 shares during the last quarter. Advocate Investing Services LLC purchased a new position in shares of Healthpeak Properties during the fourth quarter worth about $26,000. Elyxium Wealth LLC purchased a new position in shares of Healthpeak Properties during the fourth quarter worth about $31,000. Clearstead Advisors LLC grew its holdings in shares of Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after buying an additional 1,216 shares during the last quarter. Finally, CYBER HORNET ETFs LLC purchased a new position in shares of Healthpeak Properties during the second quarter worth about $33,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.